New brain scanner could sharpen epilepsy surgery targeting

NCT ID NCT07281222

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, more comfortable brain scanner (OPM MEG) that fits directly on the head to locate where seizures start in people with epilepsy. Researchers will compare its accuracy to standard methods in 70 patients aged 6 to 65 who are already scheduled for epilepsy surgery. If the device proves reliable, it could help surgeons remove the right brain area and improve seizure control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
OPM MEG device (FYNA Research)
What this could lead to
If successful, this could provide a more accurate, comfortable, and accessible way to pinpoint seizure origins, potentially improving surgical outcomes for epilepsy patients.
What could go wrong
This is an early-stage diagnostic study with only 70 participants. The device may not prove more accurate than existing methods, and results may not generalize to all epilepsy types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT PARTIAL EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Service Explorations Fonctionnelles Pédiatriques

    Bron, 69500, France

  • Hôpital Neurologique, Hospices Civils de Lyon, Service Explorations Fonctionnelles Neurologiques et Epileptologie

    Bron, 69500, France

  • Hôpital de la Timone, AP-HM Service d'Epileptologie et Rythmologie Cérébrale

    Marseille, 13005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.